Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
85 Cards in this Set
- Front
- Back
Gap junction channel is built from...
|
six identical subunits called CONNEXINS
|
|
Gap junction channels allow movement of what?
|
allows current to flow directly from one cell to the next
allows passage of small molecules (cAMP, Ca2+ that have signalling capabilities) |
|
When/where are GAP JUNCTIONS most commonly found?
|
more common durinv development (rare in the adult nervous system)
Found in some groups of neurons that need to fire synchronously (e.g., brainstem respiratory neurons) |
|
What regulates expression of the CONNEXINS that make up gap junctions
|
e.g. by steroid hormones
|
|
Permeability of GAP JUNCTIONS is regulated by:
|
second messengers
pH and Ca2+ |
|
mutations in the genes encoding different connexins are believed to underlie what diseases?
|
1. CONGENITAL RECESSIVE NONSYNDROMIC DEAFNESS
and PROGRESSIVE DOMINANT DEAFNESS 2. CHARCOT MARIE TOOTH (CMT disease) |
|
Connexin mutations can cause deafness because
|
loss of connexin expression (and therefore gap junctions) results in changes in K+ distribution in the COCHLEA and therefore...
changes the Vrest of cochlear haircells |
|
mutations in what gene may account for 10% of all congenital hearing loss
|
connexin 26
|
|
Charcot Marie Tooth (CMT) disease
|
most common hereditary peripheral neuropathy (X linked form assoc. w/ Cx32)
characterized by diminished conduction of both MOTOR AND SENSORY axons mutation results in the loss of gap junctions between overlaying intracellular loops of schwann cells resulting in demyelination mainly in paranodal regions |
|
loss of gap junctions between overlaying loops of Schwann cells underlies what disease?
|
Charcot Marie Tooth disease
characterized by diminished conduction of both: MOTOR and SENSORY axons |
|
Fundamental properties of chemical synaptic transmission
|
1. NEUROTRANSMITTER stored in PRESYNAPTIC VESICLES
2. EXOCYTOSIS of presynaptic vesicles requires INFLUX of Ca2+ ions upon depolarization 3. Specific cognate receptors for each neurotransmitter in postsynaptic membrane 4. Neurotransmitter release and opening of the postsynaptic receptors is very vast 5. variety of mechanisms terminate action of neurotransmitters |
|
what is required for exocytosis of presynpatic vesicles?
|
influx of Ca2+ ions upon depolarization
|
|
how long does it take for an action potential to travel from a presynaptic nerve terminal through the post-synaptic receptor?
|
~500 microseconds
due to fast release of neurotransmitter and opening of postsynaptic receptors |
|
specificity of chemical transmission is conferred by
|
specific cognate receptors for each neurotransmitter in postsynaptic membrane
|
|
bulk of communication in the nervous system is...
|
chemical in nature
|
|
Sequence of events in neurotransmitter release
|
1. Depolarization (by action potential) opens voltage-gated Ca2+ channels in presynaptic terminal
2. Ca influx facilitates Ca-dependent exocytosis of neurotransmitter 3. Activation of cognate post-synaptic receptors by neurotransmitter binding 4. Termination by uptake, diffusion or hydrolysis |
|
2 major classes of neurotransmitters
|
1. SMALL MOLECULES: biogenic amines (dopamine, norepi, epi, 5-HT, histamine), gultamate, GABA, glycine, ACh
2. LARGER NEUROPEPTIDES and NEUROHORMONES: over 50 id'd.. eg: opoids cannabanoids, substance P, vasopressin, oxytocin |
|
2 major classes of neurotransmitter receptors
|
1. IONOTROPIC RECEPTORS: ligand-gated ion channels (time range ~ msec)
2. METABOTROPIC NEUROTRANSMITTER RECEPTORS: G protein-coupled and activation of 2nd messenger signalling pathways (time scale :msec to minutes or longer) |
|
IONOTROPIC RECEPTORS
type of receptor: time range: |
ligand-gated ion channels
time range: msec |
|
METABOTROPIC NEUROTRANSMITTER RECEPTORS
time range: |
G protein-coupled
and activation of 2nd messenger signalling pathways time scale: msec to minutes or longer |
|
Examples of small molecule neurotransmitters
|
biogenic amines (dopamine, norepi, epi, 5-HT, histamine)
glutamate GABA glycine ACh Purines |
|
Examples of larger neuropeptide and neurohormone neurotransmitters
|
over 50 id'd
opioids cannabinoids substance P |
|
major inhibitory neurotransmitter in the brain
|
GABA (smalle molecule neurotransmitter)
|
|
what determines whether chemical transmission is inhibitory or excitatory?
|
determined by neurotransmitter receptors (which are inhibitory or excitatory)
neurotransmitters are NOT |
|
Depolarization
|
lessening of membrane potential (eg. from -70 to -40 mV)
|
|
Hyperpolarization
|
increasing of membrane potential (e.g., from -60 to -90 mV)
|
|
EPSP/EPSC
|
excitatory postsynaptic potential/current
|
|
IPSP/IPSC
|
inhibitory postsynaptic potential/current
|
|
EPP
|
specialized neuromuscular excitatory synaptic potential END PLATE POTENTIAL
|
|
Excitation:
|
change in Vm that makes it more likely that Vm will exceed the threshold for generating an action potential (depolarization)
|
|
Inhibitions
|
change in Vm that makes it less likely that Vm will exceed the threshold for generating an action potential (many times hyperpolarization but does not have to be)
|
|
nicotinic acetylcholine receptors
(skeletal muscle and neuronal) are: what type of receptors? relay what type of signal? |
Ionotropic Receptors
EXCITATORY |
|
glutamate receptors (NMDA and AMPA)
receptor type? signal type? |
Ionotropic Receptor
EXCITATORY (?mediate fast inhibition) |
|
Purinergic receptors (bind adenosine or ATP)
receptor type? signal type? |
Ionotropic Receptor
EXCITATORY |
|
GABAa receptors
found where? receptor type? signal type? |
found mainly in brain
IONOTROPIC receptors Inhibitory **excitatory in dvpg brain and adult neurons after injury |
|
Glycine receptors
found where? receptor type? signal type? |
mainly expressed in spinal cord
IONOTROPIC receptors Inhibitory **excitatory in dvpg brain and adult neurons after injury |
|
5-HT3 class of serotonin receptors
receptor type? signal type? |
IONOTROPIC
Excitatory |
|
examples of compounds that can activate both ionotropic and metabotropic receptors
|
GABA
glutamate serotonin ATP ACh |
|
muscarinic ACh receptor is what kind of receptor?
|
metabotropic receptor
|
|
nicotinic ACh receptor is what kind of receptor
|
ionotropic (excitatory) receptor
(Neuronal and skeletal muscle0 |
|
GABAb receptor is what kind of receptor?
|
metabotropic
|
|
what kind of receptors are GABAa and GABAc?
|
ionotropic
inhibitory |
|
Glutamate receptors that are
a) ioniotropic b) metabotropic |
a) NMDA
AMPA Kainate b) ACPD |
|
which class of 5-HT receptor is ionotropic?
|
5-HT 3
|
|
neurons in the CNS receive about how many synapses?
|
tens of thousands
purkinje cell dendrites covered with presynpatic terminals (eg from granule cells) |
|
neuromuscular junction involves what type of fibers?
|
involves fast twich fibers
|
|
each postsynaptic muscle fiber is innervated by...
|
a single motor neuron axon at a single well-define postsynaptic site
|
|
how efficacious is synaptic transmission at NMJs?
|
VERY HIGH efficacy
~1:1 safety factor (i.e. each action potential in the presynaptic cell gives rise to an action potential in the postsynaptic cell |
|
Multiple muscle fibers can receive synaptic input from the same
|
neuron
|
|
Active Zones of NMJ
|
site of neurotransmitter release in presynaptic membrane of NMJ
|
|
where are vesicles found in NMJs
|
docked at active zones via:
-protein complexes between vesicle and plasma membranes and.. -association with cytoskeleton in the presynaptic terminal |
|
vesicles at nmp contain what as the primary neurotransmitter?
|
ACh
|
|
What is required for exocytosis triggered by action potentials
|
Ca influx (via Voltage dependent Ca channels)
opened by depolarization from invading action potential allows vesicles to fuse to membrane and exocytose neurotransmitter |
|
Where are Ca channels found in nmj
|
localized to active zones
|
|
At nmj
Eca is greater than |
100mV
BIG driving fource both via concentration gradient and potential gradient |
|
What happens to Ca concentrations in nmj?
|
huge rise in intracellular Ca2+ only happens at active zones
normally would be dangerous, but very transient and localized |
|
what is the change in intracellular [Ca2+] at active zone of nmj triggered by an action potential?
|
increases from <nM to 100-1000 microM
|
|
Lambert-Eaton syndrome
|
muscle weakness due to impaired release of neurotransmitter from presynaptic terminals
autoimmune disease: Abs directed against presynaptic Ca2+ channels fewer Ca channels, less Ca entery with AP, fewer vesicles released Rx: K+ channel blockers produce longer APs, that allow more Ca channels to be activated and restores some vesicular release |
|
disease associated with autoantibodies against presynaptic Ca2+ channels
|
Lambert-Eaton, causes muscle weakness
Rx: K+ channel blockers to produce longer Action Potentials (to allow more Ca channels to be activated) |
|
many of what are required for vesicle fusion?
|
proteins
|
|
toxins that block exocytosis of synaptic vesicles by proteolyzing specific proteins?
|
BoTOX (Botulinum)
and Tetanus toxins inhibit chemical transmission at nmj |
|
synaptobrevin
|
vesicle membrane protein
target for tetanus toxin and Botox |
|
Syntaxin and SNAP-25
|
presynaptic membrane proteins
target for BoTox |
|
BoTox targets
|
vesicle membrane protein: synaptobrevin
and presynaptic membrane proteins: Syntaxin and SNAP-25 |
|
what is the nature of neurotransmitter release?
|
QUANTAL
(m) mean # of vesicles released per action potential = # of vesicles available for release (n) x probability of release for each vesicle (p) |
|
what effect does low [Ca2+] around a nmj have on the probability of vesicle release?
|
decreases "p"
therefore decreasing "m" |
|
what determines the quantal release of presynaptic vesicles? (m)
|
m = n*p
(n) THE NUMBER OF VESICLES AVAILABLE (p) THE PROBABILITY OF RELEASE as determined by ??enviro??? |
|
describe factors contributing to quantal release at NMJ
|
m is usually large (~300)
large amount of transmitter high probability of release |
|
describe quantal nature of vesicle release in CNS
|
m is < 1
low quantal nature of release is very important to integration of central nervous system (don't want all-or-none release as seen in nmj) |
|
AChE
|
acetylcholinesterase
terminates ACh action at the NMJ localized to the basal lamina (ECmatrix in the synaptic cleft) |
|
AChE regulates transmitter action by
|
permitting each ACh molecule to bind only once to an ACh receptor on the postsynaptic membrane, thereby limiting the time course of hte transmitter action.
|
|
why is ACh able to cross synapse (how does it survive AChE?)
|
far fewer molecules of AChE than ACh or AChR
|
|
where are ACh receptors (AChRs) found?
|
clustered at tops of postsynaptic folds
~10,000/micrometer^2 vs. 1-10micrometers^2 in the nonsynaptic membrane |
|
High Safety Factor at NMJ reflects what?
|
LARGE MEAN QUANTAL CONTENT (m)
at nmj both n and p are very high m= 300 (avg 300 vesicles of ACh released per action potential) 300 vesicles of ACh activate millions of AChRs and depolarizes postsynaptic muscle fiber well beyond threshold |
|
Tetanus toxin and BoTox interfere with synaptic transmission by:
|
cleaving
Snap-35 Syntaxin and Synaptobrevin (proteins involved in vesicular release) |
|
Myasthenia gravis
|
polyclonal antibodies against ACh receptors at the nmj
decreased density of ACh receptors simplification of junction geometry (shallow folds) |
|
How does EPP (endplate potential) differ in a normal vs. myasthenic nmj?
|
normal EPP >> threshold for generating an action potential in muscle fiber (HIGH SAFETY FACTOR)
myasthenic muscle: SAFETY FACTOR IS REDUCED even though # of quanta released is normal # of receptors is reduced and geometry of endplate facilitates transmitter diffusion (decreasing likelihood of transmission) |
|
agrin
|
motoneuron-derived factor required for ACh receptor clustering
signals through RTK called MuSK (muscle-specific kinase) some autoimmune myasthenia gravis involves auto-Abs against MuSK rather than AChR (these patients SEVERE deficits in neuromuscular transmission) |
|
MuSK
|
Receptor Tyrosine Kinase for AGRIN (factor required for AchR clustering)
some cases of myasthenia gravis involve auto-Abs against MuSK rather than AChR |
|
Anticholinesterases
|
therapeutic agents, used to treat myasthenia gravis (disease usually involving auto-Abs against AChR)
increases duration of action of ACh in synaptic cleft and probability that AChR will be activated |
|
Muscle ACh receptor is permeable to what kind of ions?
|
Na+ and K+
permeability for Na+ ions is slightly > than permeability for K+ ions |
|
What happens to Na+ and K+ ions when ACh receptor in muscle is open?
|
Na+ ions flow INTO the cell (Ena more positive than +40 mV)
K+ ions will flow out (Ek more negative than -80 mV) |
|
When ACHR is open ions will flow to drive the membrane potential toward what?
|
the Vrev (REVERAL POTENTIAL)
that is between the Ena andthe Ek (weighted by the relative permeabilities for the two ions) Thus the membrane potential will be driven slightly closer to Ena than to Ek (Vrev = ~0 mV) |
|
When AChR is open there is a NET FLUX of ions in what direction?
|
NET FLUX of positive ions into the cell
|
|
what kind of action does ACh have at the muscle AChR?
|
EXCITATORY
since the Reversal Potential of 0 mV is more depolarized than Vthreshold (Vm =~-45 mV) |